Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

Clinical trial NCT05343117 · UNKNOWN

Trial details

NCT number: NCT05343117
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Study type: OBSERVATIONAL

Hormone Receptor Positive Advanced Breast Cancer

Start date: 2021-12-01
Primary completion: 2023-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.